Início › Câncer de Próstata › Ohio › Cleveland
Ensaios clínicos de Câncer de Próstata em Cleveland, OH
34 estudos para Câncer de Próstata estão buscando participantes em locais em Cleveland e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RecrutandoFase 1/2
- The Cleveland Clinic Taussig Cancer Center, Cleveland
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
RecrutandoFase 3
- MetroHealth Medical Center, Cleveland
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RecrutandoFase 1
- University Hospitals Cleveland Medical Center, Cleveland
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
RecrutandoFase 2
- MetroHealth Medical Center, Cleveland
Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer
RecrutandoFase 2
- Case Comprehensive Cancer Center, University Hospitals Cleveland Medical Center Seidman Cancer Center, Cleveland Clinic Taussig Cancer Cente, Cleveland
Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial
Recrutando
- University Hospitals Cleveland Medical Center, Cleveland
A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer
RecrutandoFase 1
- University Hospitals Cleveland Medical Center, Cleveland
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
RecrutandoFase 3
- University Hospitals Cleveland Medical Center ( Site 0043), Cleveland
A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer
RecrutandoFase 1
- University Hospitals Cleveland Medical Center, Cleveland
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
RecrutandoFase 3
- University Hospitals Cleveland Medical Center, Cleveland
- UH Minoff Health Center at Chagrin Highlands, Orange · a 12 mi de distância
- University Hospitals Seidman Cancer Center at UH Mentor Health Center, Mentor · a 22 mi de distância
MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)
RecrutandoFase 2
- University Hospitals Cleveland Medical Center Seidman Cancer Center, Cleveland
Investigation of Impact of AI on Prostate Cancer Workflow
Recrutando
- Cleveland Clinic Foundation, Cleveland
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Recrutando
- University Hospitals Cleveland, Cleveland
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
RecrutandoFase 3
- Case Western Reserve University, Cleveland
- Louis Stokes Cleveland VA Medical Center, Cleveland
- MetroHealth Medical Center, Cleveland
- e mais 5
The Vanguard Study: Testing a New Way to Screen for Cancer
RecrutandoVoluntários saudáveis bem-vindos
- Louis Stokes Cleveland VA Medical Center, Cleveland
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
RecrutandoFase 3
- Research Site, Cleveland
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
RecrutandoFase 2
- University Hospitals Cleveland Medical Center, Cleveland
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RecrutandoFase 1/2
- University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland
- Cleveland Clinic, Cleveland
Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound
Recrutando
- Glickman Urological & Kidney Institute, Cleveland Clinic Foundation, Case Comprehensive Cancer Center, Cleveland
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
RecrutandoFase 3
- Case Western Reserve University, Cleveland
- MetroHealth Medical Center, Cleveland
- Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
- e mais 5
A Study to Learn About Real-world Utilization and Outcomes of Darolutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) for Newly Diagnosed Metastatic Hormone-sensitive Prostate Cancer (de Novo mHSPC) in US Urology Clinics
RecrutandoEstudo observacional
- Precision Point Specialty LLC PPS Analytics, a Specialty Networks LLC Company, Cleveland
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
RecrutandoFase 1
- Cleveland Clinic Foundation, Cleveland
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
RecrutandoFase 4
- Cleveland Clinic Foundation, Cleveland
STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer
RecrutandoFase 1/2
- University Hospitals Cleveland Medical Center Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
RecrutandoEstudo observacional
- University Hospitals Cleveland Medical Center, Cleveland
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
RecrutandoFase 1
- Research Site, Cleveland
Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr
Recrutando
- UH Cleveland Medical Center, Cleveland
Cleveland African American Prostate Cancer Project
RecrutandoVoluntários saudáveis bem-vindos
- Barbershops Local to Cleveland, Cleveland
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
RecrutandoFase 2/3
- Louis Stokes VA Medical Center, Cleveland, OH, Cleveland
Metabolic Impact of Prospective Controlled Mediterranean Type Diets on Prostate Cancer
Recrutando
- Case Comprehensive Cancer Center, Cleveland Clinic Foundation, Cleveland
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- Cleveland Clinic, Cleveland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecrutandoEstudo observacional
- Massive Bio SYNERGY-AI site, Mayfield Heights · a 12 mi de distância
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
RecrutandoFase 3
- MetroHealth Medical Center, Cleveland
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
RecrutandoFase 1
- Exelixis Clinical Site #7, Cleveland
Ensaios de Câncer de Próstata em outras cidades
- New York City, NY103 estudos
- Houston, TX76 estudos
- Los Angeles, CA61 estudos
- Boston, MA59 estudos
- St. Louis, MO46 estudos
- Chicago, IL45 estudos
- San Francisco, CA45 estudos
- Philadelphia, PA44 estudos
- Baltimore, MD43 estudos
- Nashville, TN42 estudos
- Seattle, WA42 estudos
- Washington, DC38 estudos
Outros estudos em Cleveland
- Câncer de Pulmão de Não Pequenas Células43 estudos
- Câncer (todos os tipos)36 estudos
- Câncer de Mama35 estudos
- Insuficiência Cardíaca33 estudos
- Câncer Metastático30 estudos
- Câncer de Ovário30 estudos
- Câncer de Pulmão26 estudos
- Câncer Colorretal24 estudos
- Doença Cardiovascular22 estudos
- Câncer Endometrial20 estudos
- Leucemia Mieloide Aguda20 estudos
- Doença de Crohn19 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.